Clinical Trial Update: Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma [NA]

View source ↗

Summary

A terminated clinical trial evaluating non-contrast arterial spin-labeled MRI to assess therapy response in metastatic renal cell carcinoma; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Renal Cell Carcinoma | NA | Status: TERMINATED | Results posted: 2025-12-19